Last reviewed · How we verify
Combiflex® lipid peri
Combiflex® lipid peri is a lipid-based perioperative formulation designed to provide nutritional support and modulate inflammatory responses during the perioperative period.
Combiflex® lipid peri is a lipid-based perioperative formulation designed to provide nutritional support and modulate inflammatory responses during the perioperative period. Used for Perioperative nutritional support.
At a glance
| Generic name | Combiflex® lipid peri |
|---|---|
| Sponsor | Chonbuk National University Hospital |
| Modality | Small molecule |
| Therapeutic area | Perioperative/Nutritional Support |
| Phase | FDA-approved |
Mechanism of action
This product appears to be a specialized lipid emulsion or nutritional support formulation intended for use in perioperative settings. Lipid-based perioperative formulations typically work by providing essential fatty acids and lipid substrates while potentially modulating immune and inflammatory responses through lipid mediators. The exact mechanism requires additional clinical documentation.
Approved indications
- Perioperative nutritional support
Common side effects
Key clinical trials
- Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combiflex® lipid peri CI brief — competitive landscape report
- Combiflex® lipid peri updates RSS · CI watch RSS
- Chonbuk National University Hospital portfolio CI